[go: up one dir, main page]

AU2003201641A1 - Treatment and diagnosis of af4-dependant diseases - Google Patents

Treatment and diagnosis of af4-dependant diseases

Info

Publication number
AU2003201641A1
AU2003201641A1 AU2003201641A AU2003201641A AU2003201641A1 AU 2003201641 A1 AU2003201641 A1 AU 2003201641A1 AU 2003201641 A AU2003201641 A AU 2003201641A AU 2003201641 A AU2003201641 A AU 2003201641A AU 2003201641 A1 AU2003201641 A1 AU 2003201641A1
Authority
AU
Australia
Prior art keywords
diagnosis
treatment
dependant
diseases
dependant diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003201641A
Other versions
AU2003201641A8 (en
Inventor
Kay Elisabeth Davies
Ann Jacqueline Hunter
Adrian Michael Isaacs
Peter Laurence Oliver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Oxford
Medical Research Council
SmithKline Beecham Ltd
Original Assignee
CHANCELLOR MASTERS
University of Oxford
Medical Research Council
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0200531A external-priority patent/GB0200531D0/en
Priority claimed from GB0200737A external-priority patent/GB0200737D0/en
Application filed by CHANCELLOR MASTERS, University of Oxford, Medical Research Council, SmithKline Beecham Ltd filed Critical CHANCELLOR MASTERS
Publication of AU2003201641A1 publication Critical patent/AU2003201641A1/en
Publication of AU2003201641A8 publication Critical patent/AU2003201641A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003201641A 2002-01-09 2003-01-07 Treatment and diagnosis of af4-dependant diseases Abandoned AU2003201641A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0200531A GB0200531D0 (en) 2002-01-09 2002-01-09 New use
GB0200531.2 2002-01-09
GB0200737.5 2002-01-11
GB0200737A GB0200737D0 (en) 2002-01-11 2002-01-11 New use
PCT/GB2003/000041 WO2003057240A2 (en) 2002-01-09 2003-01-07 Treatment and diagnosis of af4-dependant diseases

Publications (2)

Publication Number Publication Date
AU2003201641A1 true AU2003201641A1 (en) 2003-07-24
AU2003201641A8 AU2003201641A8 (en) 2003-07-24

Family

ID=26246932

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003201641A Abandoned AU2003201641A1 (en) 2002-01-09 2003-01-07 Treatment and diagnosis of af4-dependant diseases

Country Status (2)

Country Link
AU (1) AU2003201641A1 (en)
WO (1) WO2003057240A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026930A1 (en) * 1993-05-14 1994-11-24 Thomas Jefferson University Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities

Also Published As

Publication number Publication date
WO2003057240A3 (en) 2003-09-25
AU2003201641A8 (en) 2003-07-24
WO2003057240A2 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
EP1571970A3 (en) Diagnosis and monitoring of diseases
AU2002323258A1 (en) Diagnosis and treatment of vascular disease
AU2003293460A1 (en) Novel application of biosensors for diagnosis and treatment of disease
AU2002327792A1 (en) Diagnosis and treatment of diseases caused by mutations in cd72
AU2002367535A1 (en) Diagnosis and treatment of vascular disease
AU2003268531A1 (en) Materials and methods for treatment of allergic diseases
AU2003268295A1 (en) "diagnosis and treatment of infertility"
AU2003291536A1 (en) Method for the diagnosis and treatment of vascular disease
AU2002326813A1 (en) Diagnosis and treatment of vascular disease
AU2003233681A1 (en) Diagnosis and treatment of human dormancy syndrome
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2002341880A1 (en) Diagnosis and treatment of vascular disease
AU2003210266A1 (en) Treatment, diagnosis and imaging of disease
AU2002341604A1 (en) Diagnosis and treatment of vascular disease
AU2003256447A1 (en) Treatment of autoimmune skin diseases
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003222250A1 (en) Treatment of autoimmune diseases
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2002319591A1 (en) Diagnosis and treatment of vascular disease
AU2003201641A1 (en) Treatment and diagnosis of af4-dependant diseases
AU2002330713A1 (en) Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
AU2003297570A1 (en) Treatment of skin diseases
AU2003235665A1 (en) Diagnostic and therapeutic uses of topors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase